Revenues in USD of Lipocine Inc. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Lipocine Inc. quarterly and annual Revenues history and change rate from Q3 2011 to Q3 2025.
  • Lipocine Inc. Revenues for the quarter ending 30 Sep 2025 was $114,574.
  • Lipocine Inc. annual Revenues for 2024 was $11,198,144.
  • Lipocine Inc. annual Revenues for 2023 was $2,850,818, a 670% decline from 2022.
  • Lipocine Inc. annual Revenues for 2022 was $500,000.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Lipocine Inc. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $114,574 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $622,849 +$533,284 +595% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $93,864 -$7,523,310 -99% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q2 2024 $89,565 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 $7,617,174 +$7,562,184 +13752% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q3 2023 $3,121,996 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q1 2023 $54,990 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q3 2020 $0 -$164,990 -100% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q4 2019 $164,990 $0 $0 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $164,990 $164,990 +$164,990 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $0 $0 $0 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $0 $0 -$428,031 -100% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $428,031 $0 $0 01 Oct 2018 31 Dec 2018 10-K 06 Mar 2019 2018 FY
Q3 2018 $428,031 $0 $0 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $428,031 $0 $0 01 Apr 2018 30 Jun 2018 10-K 06 Mar 2019 2018 FY
Q1 2018 $428,031 $428,031 +$428,031 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q4 2017 $0 $0 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 $0 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $0 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $0 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q1
Q3 2013 $0 $0 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2013 2013 Q3
Q3 2012 $0 $0 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013 2013 Q3
Q3 2011 $0 01 Jul 2011 30 Sep 2011 10-Q 26 Oct 2012 2012 Q3

Lipocine Inc. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,198,144 +$14,048,962 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $2,850,818 -$3,350,818 -670% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $500,000 -$15,640,838 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $16,140,838* +$16,140,838 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2023 2022 FY
2020 $0 -$164,990 -100% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2021 2020 FY
2019 $164,990 -$263,041 -61% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $428,031 +$428,031 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $0 $0 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $0 01 Jan 2016 31 Dec 2016 10-K 06 Mar 2019 2018 FY
2013 $0 -$7,709,671 -100% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2014 2013 FY
2012 $7,709,671 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.